Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02690948
Title Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Anne Chang
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University School of Medicine Palo Alto California 94304 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field